(2007) for a detailed description of these requirements
The most common site is the abdominal fat, a few inches to the side of the navel
Insulin-signaling interest (inositol): Oral myo-inositol has mixed RCT-level data for insulin-resistance markers in PCOS but those trials use grams orally, not the small injected amounts in MIC, and are not weight-loss trials [6]
Future therapies in the GLP-1 pipeline include more effective new drugs like dual-action agonists, oral pill versions for weight loss, and combination therapies designed to preserve muscle mass during weight loss
Without adequate muscle preservation strategies, many individuals find their weight loss plateaus earlier than expected and weight regain becomes more likely after stopping treatment
This combination helps maintain skin glow, protect against oxidative stress, and support healthy ageing from within